Kyle Bass Group Gets PTAB To Eye Pozen Drug Patent
The Patent Trial and Appeal Board agreed Monday to review a patent on Pozen Inc.'s arthritis and ulcer drug Vimovo in an inter partes review requested by an organization started by...To view the full article, register now.
Already a subscriber? Click here to view full article